Home | Publications | Country place holder
place holder place holder

Country


Pharmaceuticals in the Netherlands


Publication Date   December 2007
Publisher   Datamonitor
Product Type   Strategic Report
Pages   36
ISBN Number   not applicable
Product Code   DAT863
Ask a question about this product?

Price £125.00

approximately: $248 | €159

Summary


The Pharmaceuticals in the Netherlands industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

  • Contains an executive summary and data on value, volume and/or segmentation
  • Provides textual analysis of the industry's recent performance and future prospects
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Includes a five-year forecast of the industry
  • The leading companies are profiled with supporting key financial metrics
  • Supported by the key macroeconomic and demographic data affecting the market

Highlights

  • Detailed information is included on market size, measured by value and/or volume
  • Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
  • Market shares are covered by manufacturer or brand

Why you should buy this report

  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research

Market Definition

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2006 annual average exchange rates.

For the purpose of this report Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Content


  • Executive Summary
  • Chapter 1 Market Overview
    • 1.1 Market Definition
    • 1.2 Research Highlights
    • 1.3 Market Analysis
  • Chapter 2 Market Value
  • Chapter 3 Market Segmentation I
  • Chapter 4 Market Segmentation Ii
  • Chapter 5 Market Share
  • Chapter 6 Five Forces Analysis
    • 6.1 Summary
    • 6.2 Buyer Power
    • 6.3 Supplier Power
    • 6.4 New Entrants
    • 6.5 Substitutes
    • 6.6 Rivalry
  • Chapter 7 Leading Companies
    • 7.1 Astrazeneca Plc
    • 7.2 Pfizer Inc
    • 7.3 Akzo Nobel N.V.
    • 7.4 Glaxosmithkline Plc
  • Chapter 8 Market Forecasts
    • 8.1 Market Value Forecast
  • Chapter 9 Macroeconomic Indicators
  • Chapter 10 Appendix
    • 10.1 Methodology
    • 10.2 Industry Associations
    • 10.3 Related Datamonitor Research
  • List Of Tables
    • Table 1: Netherlands Pharmaceuticals Market Value: $ Million, 2003-2007
    • Table 2: Netherlands Pharmaceuticals Market Segmentation I: % Share, By Value, 2007
    • Table 3: Netherlands Pharmaceuticals Market Segmentation Ii: % Share, By Value, 2007
    • Table 4: Netherlands Pharmaceuticals Market Share: % Share, By Value, 2007
    • Table 5: Key Facts: Astrazeneca Plc
    • Table 6: Key Financials: Astrazeneca Plc
    • Table 7: Key Facts: Pfizer Inc
    • Table 8: Key Financials: Pfizer Inc
    • Table 9: Key Facts: Akzo Nobel N.V.
    • Table 10: Key Financials: Akzo Nobel N.V.
    • Table 11: Key Facts: Glaxosmithkline Plc
    • Table 12: Key Financials: Glaxosmithkline Plc
    • Table 13: Netherlands Pharmaceuticals Market Value Forecast: $ Million, 2007-2012
    • Table 14: Netherlands Size Of Population (Million) , 2003-2007
    • Table 15: Netherlands Gdp (Constant 2000 Prices, $ Billion), 2003-2007
    • Table 16: Netherlands Inflation, 2003-2007
    • Table 17: Netherlands Exchange Rate, 2003